Training scientists to understand immune system diseases
Immunological Mechanisms of Disease Training Program
This program at Vanderbilt University is designed to teach students and researchers about how the immune system works in relation to diseases, helping them discover new ways to treat chronic inflammation and cancer while promoting responsible research practices.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10640277 on NIH RePORTER |
What this research studies
The Immunological Mechanisms of Disease Training Program at Vanderbilt University aims to educate pre- and postdoctoral trainees on the basic immunologic mechanisms that underlie human diseases. This program focuses on integrating knowledge of inflammation and tissue function to foster novel discoveries in immunology. Trainees will learn how to translate these discoveries into potential therapies for chronic inflammatory diseases and cancer, emphasizing responsible research practices. The program utilizes an interdisciplinary approach, drawing on expertise from various fields within the Vanderbilt scientific community.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by chronic inflammatory diseases or cancer.
Not a fit: Patients with acute, non-inflammatory conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies and interventions for diseases related to immune system dysfunction.
How similar studies have performed: Other training programs in immunology have shown success in advancing the understanding of immune-related diseases and developing new treatment strategies.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Rathmell, Jeffrey C. — Vanderbilt University
- Study coordinator: Rathmell, Jeffrey C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.